JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $549,000 | -44.4% | 12,000 | -45.5% | 0.00% | -60.0% |
| Q3 2017 | $987,000 | -28.1% | 22,000 | -38.4% | 0.01% | -28.6% |
| Q2 2016 | $1,372,000 | -6.2% | 35,692 | -7.0% | 0.01% | 0.0% |
| Q1 2016 | $1,463,000 | -75.4% | 38,397 | -71.6% | 0.01% | -75.9% |
| Q4 2015 | $5,950,000 | -14.9% | 135,310 | -21.3% | 0.03% | -23.7% |
| Q3 2015 | $6,994,000 | +48.8% | 171,887 | +95.1% | 0.04% | +81.0% |
| Q2 2015 | $4,699,000 | -5.1% | 88,112 | +7.9% | 0.02% | -4.5% |
| Q1 2015 | $4,952,000 | +16.1% | 81,628 | -0.1% | 0.02% | +4.8% |
| Q4 2014 | $4,266,000 | – | 81,698 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 2,168,601 | $65,080,000 | 86.12% |
| Crestline Management, LP | 17,348,799 | $520,637,000 | 66.02% |
| Omega Fund Management, LLC | 1,229,512 | $36,898,000 | 28.17% |
| SIB LLC | 100,000 | $3,001,000 | 2.42% |
| Clarius Group, LLC | 117,896 | $3,538,000 | 1.65% |
| BB BIOTECH AG | 1,405,000 | $42,164,000 | 1.48% |
| Duquesne Family Office | 493,000 | $14,795,000 | 1.31% |
| First Washington CORP | 65,320 | $1,960,000 | 1.10% |
| PFM Health Sciences, LP | 1,124,285 | $33,740,000 | 0.99% |
| Partner Investment Management, L.P. | 18,376 | $551,000 | 0.82% |